Primary Care Sales Specialist

Mark L. Morrison – Page * of *

Mark L. Morrison 727-***-****

Clearwater, FL ****************@*****.***

LinkedIn: mark-morrison

Summary of Pharmaceutical sales professional with hospital sales success in cardiology Qualifications and infectious disease. Increased market share by developing creative solutions to ensure best patient outcomes while meeting hospital needs. Extensive background in marketing to primary care physicians and specialists. Key Strengths Territory management Formulary positioning Market share expansion Managed care

Budget planning and control Product launches

Delivery of product training for selling teams Seminar planning and coordination Completed rare disease training program Competitive research and sales analytics Career History

Mar 2007 ASTRAZENECA PHARMACEUTICALS – Wilmington, DE to present Cardiovascular Sales Specialist – Hospital – Multi-County Florida Territory (2015-present) Products: Brilinta (anti-platelet), Farxiga (heart failure), Crestor (LDL reduction).

Strengthen products’ positions on hospital formularies: Initiate contact and establish relationships with cardiologists and key decision makers, including Pharmacy Directors, Cath Lab Directors, Clinical Pharmacists and Nurse Navigators. Present drug pharmacology and data on clinical outcomes.

Establish Brilinta on STEMI and NSTEMI protocols.

Provide clinical outcomes data to support the Cardiology Fellowship Programs at Tampa General Hospital, Lakeland Regional Health and USF Medical Center.

Provide teleconference and seminar training to district and regional selling teams: Topics include product knowledge, disease states, clinical trials, clinical data presentation, treatment guideline updates and selling techniques. ACHIEVEMENTS

Achieved formulary acceptance for Farxiga: AdventHealth (2024) and Lakeland Regional Health formulary (2022).

Placed Farxiga on Heart Failure Clinic order set: Lakeland Regional Health (2022). Increased market share 15% at Lakeland Clinics.

Significantly increased unit sales of Brilinta at Tampa General Hospital: 95% from 2016 to 2017 and 57.5% from 2017 to 2018.

Established Brilinta on STEMI protocol in 2017 at St. Joseph’s Hospital: Increased sales 30% in the first year.

Placed Brilinta on Hillsborough County formulary in 2017 and in the Pyxis of cath labs at three hospitals in 2015 and 2016: Tampa General Hospital, AdventHealth Tampa, and St. Joseph's Hospital.

2022 We Play to Win Award, 2021 Impact Award, 2018 Circle of Excellence Award for Brilinta, 2017 District MVP.

Pharmaceutical Sales Specialist – Pinellas County, FL (2007-2015) Products: Symbicort (respiratory), 2007-2014; Onglyza and Kombiglyze XR (diabetes), 2011-2015; Crestor, 2009-2011; Nexium and Seroquel (anti-psychotic), 2007-2009.

Marketed to primary care physicians, internists, endocrinologists, gastroenterologists, allergists and pulmonologists.

Provided teleconference and seminar training to district and regional salesforces. ACHIEVEMENTS

Instrumental in increasing the Clearwater District's Symbicort market share by 4% in 2014: Selected to lead a district team effort targeting 20 key allergists and pulmonologists. Led development of call strategies and clinical data presentations. Recruited key influencers and coordinated educational seminars.

Increased Onglyza market share by 6.41% in 2011. Mark L. Morrison – Page 2 of 2

Increased Crestor market share by 2.3% in 2009: Ranked in top 5% among 95 regional reps for market share increase.

Increased Seroquel market share by 4.14% in 2008: Ranked #1 in the Clearwater District and #2 in the Florida Region for market share increase. 1996 to 2007 ROCHE LABORATORIES, INC. – Nutley, NJ Acute Care (Hospital) Representative – Pinellas County, FL (2004-2007) Products: Rocephin (antibiotic), Kytril (antiemetic), Tamiflu (antiviral) and Boniva

(bisphosphonate).

Placed products on formularies of 8 hospitals: Established accounts with all Baycare and HCA systems in Pinellas County.

Partnered with national account managers in negotiations with hospitals and government healthcare facilities.

ACHIEVEMENTS

Ranked #1 in Pinellas District and Top 10% in the nation in Boniva injectable sales in 2006.

Generated Boniva injectable sales of $72,000 at Largo Medical Center in 2006: Introduced the concept of a Boniva Infusion Center to this multispecialty group with 120+ physicians, which they implemented.

Increased sales of Rocephin at Mease Morton Plant Hospital by $298,000 and at Suncoast Hospital by 16% in 2005: Succeeded in securing Rocephin's place on the Pneumonia Guidelines as the preferred treatment in both hospitals.

Increased market share of Rocephin by 38% in the territory in 2004: Gained access to HCA hospitals in Clearwater, FL, by persuading HCA's microbiologist to test susceptibility of pathogens to Rocephin. Utilized the hospitals' antibiograms to demonstrate clinical benefits of Rocephin to key hospital decision makers.

Instrumental in a $6M revenue gain in HCA hospitals nationwide in 2004: This national gain was a consequence of Clearwater HCA's formulary acceptance of Rocephin.

Primary Care Representative – Pinellas County, FL (1996-2004) Products: Rocephin, Tamiflu and Coreg (beta blocker).

Marketed to primary care physicians, internists and cardiologists. ACHIEVEMENTS

Launched Tamiflu in 2001 and built market share of 80% in Pinellas County by 2003: Ranked in Top 10% in the nation (2003).

Increased Rocephin sales at two hospitals by $118,000 in 2002: Conceptualized and supported the launch of two Outpatient Antibiotic Treatment Centers

(OPATs) in HCA Community and North Bay hospitals.

Education B.A., History and Education; Minor in Physical Education – Adrian College – Adrian, MI

Inducted into Adrian College Athletic Hall of Fame for Football (2000) Computer Skills MS Office: Word, Excel, PowerPoint CRM: Salesforce, Veeva, Workday

Virtual engagement: Zoom, Teams

Contact this candidate